secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001214659-25-014950
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro eliminates Series B and Series C convertible preferred stock
---------------------------------------------------------------------------

- Filed Certificates of Elimination for Series B and Series C convertible preferred stock with Delaware Secretary of State on October 14, 2025.
- The elimination removes all matters set forth in the Certificates of Designations for those preferred stock series from the company's charter.
- No other changes to the capital structure, financial terms, or stock trading were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925014950/0001214659-25-014950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925014950/b10142528k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-25-014950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer